Furthermore, ALA can decrease serum BNP and cardiac hypertrophy through attenuating the mRNA and protein levels of C/EBPβ which is responsible for cardiomyocyte hypertrophy [47]. The gene discussed is NPPB; the disease is cardiac hypertrophy.